(19)
(11) EP 2 254 575 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
22.06.2016 Bulletin 2016/25

(45) Mention of the grant of the patent:
04.05.2016 Bulletin 2016/18

(21) Application number: 09712628.8

(22) Date of filing: 18.02.2009
(51) International Patent Classification (IPC): 
A61K 31/4172(2006.01)
(86) International application number:
PCT/GB2009/000430
(87) International publication number:
WO 2009/103959 (27.08.2009 Gazette 2009/35)

(54)

ORAL L-HISTIDINE FOR THE TREATMENT OR PREVENTION OF ATOPIC DERMATITIS OR CONTACT DERMATITIS

ORAL L-HISTIDIN ZUR BEHANDLUNG ODER PRÄVENTION DER ATOPISCHEN DERMATITIS ODER KONTAKTDERMATITIS

ORAL L-HISTIDINE POUR LE TRAITEMENT OU LA PREVENTION DE LA DERMATITE ATOPIQUE OU DERMITE DE CONTACT

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

(30) Priority: 20.02.2008 GB 0803054

(43) Date of publication of application:
01.12.2010 Bulletin 2010/48

(73) Proprietor: Curapel (Scotland) Limited
Glasgow G2 4JR (GB)

(72) Inventor:
  • GIBBS, Neil, Kerslake
    Cheshire CW4 8BY (GB)

(74) Representative: Hewson, Timothy John et al
Abel & Imray 20 Red Lion Street
London WC1R 4PQ
London WC1R 4PQ (GB)


(56) References cited: : 
WO-A-2004/071208
DE-A1- 4 328 871
JP-A- 58 164 516
JP-A- 2008 031 066
 DE-A1- 4 307 983
DE-A1- 10 141 780
JP-A- 2005 120 007
   
  • REILLY S K ET AL: "Dietary histidine increases mouse skin urocanic acid levels and enhances UVB-induced immune suppression of contact hypersensitivity." PHOTOCHEMISTRY AND PHOTOBIOLOGY APR 1991, vol. 53, no. 4, April 1991 (1991-04), pages 431-438, XP008107201 ISSN: 0031-8655
  • MORISON ET AL: "Phototherapy and photochemotherapy: An update" SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, W.B. SAUNDERS, PHILADELPHIA, US, vol. 18, no. 4, 1 December 1999 (1999-12-01), pages 297-306, XP005468114 ISSN: 1085-5629
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).